Metraipolis › archive › dc_1101decdc826
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study — Europe PMC PMID:42342288
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42342288
- DOI
- 10.1136/rmdopen-2025-006657
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T04:44:40.642Z
- SHA-256 of the archived text
86d70bb832df4e53b9918181ca63eaa61ecbee076cc5d63b8318ffec6d684e33- Stable URL of this page
https://metraipolis.com/documento/dc_1101decdc826
How to cite
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study — Europe PMC PMID:42342288 — Europe PMC (en), https://europepmc.org/article/MED/42342288 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1101decdc826 (Metraipolis archive dc_1101decdc826, sha256 86d70bb832df4e53b9918181ca63eaa61ecbee076cc5d63b8318ffec6d684e33)
BibTeX
@misc{dc1101decdc826,
title = {Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study — Europe PMC PMID:42342288},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42342288},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1101decdc826; sha256 86d70bb832df4e53b9918181ca63eaa61ecbee076cc5d63b8318ffec6d684e33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42342288. Agents can read the archived copy with the MCP tool read_document.